Amerimmune is an immunology and allergy center serving children and adults, including patients with complex or unresolved health concerns. The organization combines clinical care, advanced diagnostics, research, and bio ventures through an integrated, research-driven model. Patients can visit five clinics in McLean, Alexandria, Arlington, Bethesda, and Gaithersburg, or access telehealth services in 15 states and Washington, DC. Home visits for immune testing and walk-in blood draws are also available.

Amerimmune offers allergy and immunology consultations, allergy testing, immune evaluations, and specialized diagnostic services through its CAP-accredited laboratory. Its proprietary flow cytometry panels assess more than 100 immune markers. Tests include standard immunophenotyping, basophil activation testing, progenitor eosinophil analysis, COVID immune phenotyping, Th1 response assessment, and inflammasome testing. The center also provides immune testing for patients’ immediate family members.

Amerimmune conducts research connected to patient care, reporting more than 40 peer-reviewed publications, four active patents, and three key discoveries. Its bio ventures aim to translate immune science into diagnostics, therapeutic insights, and partnerships.